A mid-gut microbiota is not required for the pathogenicity of Bacillus thuringiensis to diamondback moth larvae by Raymond, B et al.
  
 
 
 
 
 
A mid-gut microbiota is not required for the pathogenicity 
of Bacillus thuringiensis to diamondback moth larvae. 
 
 
Journal: 
Environmental Microbiology and Environmental Microbiology 
Reports 
Manuscript ID: EMI-2009-0285.R1 
Manuscript Type: EMI - Research article 
Journal: Environmental Microbiology 
Date Submitted by the 
Author: 
26-May-2009 
Complete List of Authors: Raymond, Ben; University of Oxford, Dept of Zoology 
Johnston, Paul; University of Sussex, Biochemistry 
Wright, Denis; Imperial College 
Ellis, Richard 
Crickmore, Neil; University of Sussex, Biochemistry 
Bonsall, Michael; University of Oxford, Department of Zoology 
Keywords: 
population biology/clonal structure, pathogen ecology, symbionts, 
microbial ecology, theoretical ecology 
  
 
 
 
Society for Applied Microbiology, Editors: K. Timmis, D. Stahl, E. DeLong, M. Wagner, M. Jetten, J.L. Ramos
 1 
 1 
A mid-gut microbiota is not required for the pathogenicity of Bacillus 2 
thuringiensis to diamondback moth larvae. 3 
 4 
Ben Raymond*1, Paul R. Johnston2, Denis J. Wright3, Richard J. Ellis4†, 5 
Neil Crickmore2, Michael B. Bonsall1. 6 
 7 
 8 
1 Mathematical Ecology Research Group, Dept of Zoology, University of Oxford, 9 
South Parks Road, Oxford, OX1 3PS, UK. 10 
2
 Department of Biochemistry, School of Life Sciences, University of Sussex, Falmer, 11 
Brighton, BN1 9QG, UK 12 
3 Division of Biology, Faculty of Natural Science, Imperial College London, Silwood 13 
Park campus, Ascot, SL5 7PY, UK. 14 
4 NERC Centre for Population Biology, Imperial College London, Silwood Park 15 
Campus, Ascot, SL5 7PY, UK * Correspondence: Email: 16 
benjamin.raymond@zoo.ox.ac.uk; tel. 0044 1865 271132; fax 0044 1865 310447. 17 
† Current address: Molecular Pathogenesis and Genetics, Veterinary Laboratories 18 
Agency, Addlestone, KT15 3NB, UK 19 
 20 
Page 2 of 30
Society for Applied Microbiology, Editors: K. Timmis, D. Stahl, E. DeLong, M. Wagner, M. Jetten, J.L. Ramos
 2 
Summary 1 
The mode of action of the entomopathogenic bacterium Bacillus thuringiensis is 2 
still a matter of debate.  Recent reports have claimed that aseptic lepidopteran 3 
hosts were not susceptible to B. thuringiensis (Bt) and that inoculation with mid-4 
gut bacteria restores pathogenicity.   These claims are controversial because 5 
larvae were rendered aseptic by consuming antibiotics, although the effect of 6 
these antibiotics on Bt was not examined.  We tested the generality of the mid-gut 7 
bacteria hypothesis in the diamondback moth, Plutella xylostella using properly 8 
controlled experiments that investigated the effect of antibiotic consumption and 9 
absence of gut microbiota separately.  We found that purified Bt toxin and 10 
spore/toxin mixtures were fully pathogenic to larvae reared aseptically.  11 
Persistence of antibiotics in larval tissues was implicated in reducing host 12 
mortality since larval consumption of the antibiotic rifampicin reduced the 13 
pathogenicity of rifampicin sensitive Bt strains but not rifampicin resistant 14 
strains.  Inoculating larvae with Enterobacter sp.  Mn2 reduced the mortality of 15 
larvae feeding on Bt HD-1 and the presence of a culturable gut microbiota also 16 
reduced the pathogenicity of the Bt toxin Cry1Ac, in agreement with other 17 
studies indicating that an intestinal microbiota can protect taxonomically diverse 18 
hosts from pathogen attack. Since ingestion of antibiotics suppresses host 19 
mortality the vegetative growth of Bt in the host must be important for its 20 
pathogenicity.  Furthermore, claims that aseptic larvae are not susceptible to Bt 21 
must be supported by experiments that control for the effect of administering 22 
antibiotics. 23 
 24 
 25 
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Introduction 1 
Bacillus thuringiensis (Bt) is a gram positive spore forming invertebrate pathogen that 2 
is widely exploited in pest management. Its utility derives from the large quantities of 3 
proteinaceous toxins that form crystalline parasporal inclusions, termed the Cry and 4 
Cyt proteins (Schnepf et al., 1998). Bt toxin genes have been widely incorporated into 5 
genetically modified insect resistant crops (ISAAA, 2007) but are also widely 6 
exploited as biopesticides with target hosts ranging from mosquitoes to lepidopteran 7 
pests of horticulture and foresty (Glare and O'Callaghan, 2000).  Although the 8 
structure and mode of action of Bt Cry toxins has been intensively researched, the 9 
biology and ecology of the bacterium is not fully characterized (Jensen et al., 2003; 10 
Raymond et al., 2008a). Disagreement on the biology of Bt extends to the exact 11 
mechanism responsible for the death of the host.  A purely toxin based hypothesis 12 
suggests that the action of predominantly Cry toxins paralyses the mid-gut and leads 13 
to eventual death by starvation (Knowles, 1994).  Alternatively, Cry toxins cause 14 
extensive cell lysis in the mid-gut that allows bacteria access to the haemolymph, thus 15 
rapid vegetative growth of Bt within the host (septicaemia) is proposed as an 16 
alternative cause of death (Schnepf et al., 1998). 17 
Recently, a novel pathogenic mechanism was suggested by the claim that Bt 18 
and its toxins are incapable of killing aseptically reared gypsy moth, Lymantria 19 
dispar, larvae but that pathogenicity can be restored by inoculating hosts with a gut-20 
associated strain of Enterobacter (Broderick et al., 2006).   More recent work has 21 
extended this claim to a wide range of insect hosts (Broderick et al., 2009).  An 22 
obligate association with the gut microbiota challenges previous models of the 23 
pathogenicity of Bt toxins, and has considerable implications for the ecology of Bt and 24 
the evolution of novel resistance mechanisms in invertebrate pests. The gut 25 
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microbiota hypothesis remains highly controversial, given previous evidence of the 1 
lethality Bt in aseptically-reared insects (Takatsuka and Kunimi, 2000) and the 2 
synergistic action of the Bt spore on the toxicity of crystal toxins in some hosts 3 
(Heimpel and Angus, 1959; Li et al., 1987; Liu et al., 1998).  4 
Moreover, the experimental findings of Broderick et al. (2006, 2009) suffer 5 
from two issues that may confound their results.  First, the authors administered high 6 
doses of four broad-spectrum antibiotics to hosts in order to eliminate their gut 7 
microbiota, but they did not directly control for the effects of antibiotics on Bt itself.  8 
Second the work exclusively used a strain of Bt (B. thuringiensis subsp. kurstaki HD-9 
1) that was isolated from a commercial biopesticide (DiPel DF). This strain grows 10 
poorly in some hosts (Raymond et al., 2008a) and while the precise evolutionary 11 
background of this strain is unknown, biopesticide strains are typically selected for 12 
increased toxin production in artificial media and may have undergone little recent 13 
selection in live hosts. 14 
Here we aimed to test the applicability of the claim that a culturable gut 15 
microbiota is required for the pathogenicity of Bt and its Cry toxins in an alternative 16 
host, the diamondback moth, Plutella xylostella, and by using protocols which 17 
produced aseptic larvae without directly administering antibiotics. More specifically, 18 
we tested two hypotheses: (1) that strain attenuation in biopesticides leads to a 19 
dependence on culturable gut microbiota for pathogenicity and (2) that the carry-over 20 
of ingested antibiotics in host larvae can reduce the pathogenicity of Bt.  21 
 22 
Results 23 
Toxicity of purified Bt Cry1Ac protoxin in aseptic and conventionally reared larvae 24 
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Cry1Ac toxicity bioassays showed that a culturable midgut microbiota was not 1 
required to induce host mortality.  Moreover, purified protoxin was approximately 2 
twice as lethal in aseptically reared larvae in comparison to larvae with a well-3 
developed gut microbiota (Table 2; effect of rearing treatment χ2 = 52.0, df = 1, P 4 
<<0.0001; log-transformed assay dose χ2 = 467.0, df = 1, P <<0.0001). We found that 5 
16S rRNA genes could not be amplified from aseptically reared DBM larvae (15/15 6 
larvae) whereas amplicons were consistently produced from non-sterile larvae reared 7 
in the absence of antibiotics (15/15 larvae). Similarly, culturable bacteria were only 8 
found within the non-sterile larvae.  Note that these non-sterile larvae were derived 9 
from non-sterile parents in contrast to the bacterial bioassays below. Sequencing of a 10 
subset of gut bacteria from this population showed that this population is typically 11 
colonized by Enterococcus spp. and that Enterobacter sp. isolates were relatively rare.   12 
 13 
Testing the pathogenicity of biopesticidical, wild-type and host passaged Bt strains in 14 
aseptically-reared and Enterobacter inoculated larvae 15 
We investigated whether attenuation in strains derived from biopesticides would 16 
affect their ability to kill aseptic hosts.  To this end we compared the pathogenicity of 17 
three biopesticidal strains; three wild type isolates of Bt and three passaged strains 18 
(R1-K, R2-K and R3-K) in aseptically-reared rifampicin fed P. xylostella larva.  All 19 
passaged strains were originally isolated from a spontaneous rifR mutant of the 20 
biopesticide DiPel WP (B. thuringiensis kurstaki HD-1) and subsequently infected 21 
and re-isolated three times in P. xylostella larvae.  22 
If strain attenuation had affected the pathogenicity of Bt biopesticides in 23 
aseptic hosts then WT and host passaged strains should incur higher mortality rates 24 
than the biopesticide strains in the absence of any gut microbiota.  In addition, if the 25 
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gut microbiota hypothesis is general none of the nine isolates in this experiment 1 
should be pathogenic to these hosts.  We found neither of these patterns. The passaged 2 
rifampicin resistant (rifR) strains were highly pathogenic to aseptic, rifampicin treated 3 
P. xylostella and there were clear differences in the mortality imposed by the three 4 
groups of stains (binomial glm F2,23 = 77.1, P < 0.0001; Figure 1).  Comparisons 5 
(using post hoc treatment contrasts) between these groups of strains showed that the 6 
rifR strains were more pathogenic than either the WT (t = 8.68, P < 0.0001) or the 7 
biopesticide strains (t = 5.26, P < 0.0001)  (Figure 1). Overall, strains isolated from 8 
similar sources had similar pathogenicity, i.e. there was no significant effect of 9 
pooling strains into their three groups (biopesticides, wild-type, and passaged strains)  10 
(F9,21 = 1.08, P = 0.47). Bioassay dose had a strong effect on larval mortality (F1,25 = 11 
9.72, P < 0.0001) and increasing bioassay doses had less effect on the pathogenicity  12 
of WT and biopesticide strains (dose X strain interaction F2,21 = 7.20, P = 0.004).  13 
Dose effects have not been plotted for graphical simplicity (Figure 1). 14 
 15 
Distinguishing between the effect of antibiotic treatment and absence of gut 16 
microbiota on the pathogenicity of Bt 17 
There were two possible explanations for the results of the previous experiment, 18 
either rifampicin in larval diet was persisting in larval hosts and inhibiting Bt 19 
pathogenicity or culturable mid-gut microbiota are required for the pathogenicity of 20 
both WT and biopesticide strains but not the recently passaged rifR strains.  We 21 
conducted two full factorial experiments with different isolates of Bt to tease apart 22 
these explanations and to test whether the absence of gut microbiota or treatment with 23 
antibiotics was responsible for inhibiting the pathogenicity of a proportion of Bt 24 
strains.  These experiments used both antibiotic sensitive and rifR strains of Bt HD-73 25 
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and Bt HD-1 strains.  In these experiments the majority of larvae died by the end of 1 
the five-day observation period and survival data was analysed using a Cox 2 
proportional hazard model.  As above, all treatments were replicated at three doses of 3 
Bt with approximately 30 larvae per dose.  The experiments with HD1 and HD73 4 
used the same generation of insects, however, the HD1 experiment was initiated a 5 
week earlier with second instar larvae; the HD73 experiment used third instar larvae. 6 
 7 
In both experiments antibiotic sensitive strains of Bt were pathogenic to larvae reared 8 
aseptically without antibiotics (Fig. 2, Fig. 3), and there was no evidence that absence 9 
of a culturable gut microbiota was inhibiting the pathogenicity of this bacterium.  In 10 
contrast, we did find evidence that carry-over of antibiotics in hosts could affect the 11 
pathogenicity of Bt:  larval consumption of rifampicin substantially reduced the 12 
pathogenicity of all antibiotic sensitive strains, but did not reduce the mortality of the 13 
rifR strains (HD-1 experiment: strain*diet interaction df = 1, residual df = 824, χ2 = 14 
250, P << 0.001; HD-73 experiment: strain*diet interaction df = 1, residual df = 761, 15 
χ
2 
= 37, P << 0.001).    16 
The effect of inoculation with Enterobacter sp. Mn2 was different in the two 17 
experiments.  In the HD-1 experiment the presence of Enterobacter sp. Mn 2 had a 18 
small but significant effect on reducing the pathogenicity of both the rifampicin 19 
susceptible and the rifR strain  (df = 1, residual df = 824, χ2 = 6.0, P = 0.014; Fig 2). 20 
Note that the survivorship analysis can only differentiate between treatments when 21 
mortality is below 100%.  However, inoculation with Enterobacter sp. Mn2 did not 22 
alter the pathogenicity of Bt HD-73 (df = 1, residual df = 763, χ2 = 0.1, P = 0.8, Fig. 23 
3).  Bioassay dose affected mortality rates in the HD-1 experiment and interacted with 24 
pathogen strain (df = 1, residual df = 824, χ2 = 156.2, P < 0.0001) but not 25 
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Enterobacter sp. Mn2 inoculation (df = 1, residual df = 823, χ2 = 1.9, P = 0.2), or the 1 
application of rifampicin (df = 1, residual df = 822, χ2 = 1.54, P = 0.12).  In the HD-2 
73 experiment dose also significantly affected mortality (χ2 = 8.5, P <0.0001) but did 3 
not interact with bacterial strain (df = 1, residual df = 759, χ2 = 1.7, P = 0.2) or 4 
Enterobacter sp. Mn2 inoculation (df = 1, residual df = 760, χ2 = 1.1, P = 0.3) but did 5 
interact with rifampicin consumption (df = 1, residual df = 761, χ2 = 7.2, P = 0.007).  6 
 7 
We examined control insects from the first two bacterial bioassays for the presence of 8 
culturable strains (using high-nutrient LB agar) and unculturable bacteria (using PCR 9 
amplification of 16S rRNA genes).  Larvae were removed at the end of the 10 
experiment for DNA extraction, in order to maximize the probability of recovering 11 
contaminants. Homogenized whole larvae from both the antibiotic-free and 12 
rifampicin-diet rearing treatments failed to produce any bacterial colonies when plated 13 
on LB media (n=10 per treatment).  In contrast, 60% of whole insect homogenates 14 
from larvae inoculated with Enterobacter sp. Mn2 contained detectable culturable 15 
levels of this bacterium ranging 0 - 3x103 CFU per insect on antibiotic free diet and 0 16 
- 4x101 CFU per insect on rifampicin diet, although there was no significant 17 
difference between diet treatments (df = 13, t = 1.46, P = 0.17). PCR conditions that 18 
were sufficiently sensitive to amplify a product from 40 pg of Enterobacter sp. 19 
template DNA, roughly equivalent to 104 cells of Escherichia coli (Kubitschek and 20 
Friedman, 1971), failed to amplify a product from larvae reared-aseptically on 21 
antibiotic-free diet.  We could, however, recover visible PCR products from 5/8 22 
aseptically-reared larvae that were experimentally inoculated with Enterobacter sp. 23 
Mn2.  24 
 25 
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 1 
 2 
Discussion 3 
We have shown that both Bt toxins and spore/toxin mixtures are pathogenic in 4 
the absence of midgut bacteria when carry-over effects of antibiotic are excluded by 5 
using aseptically reared hosts.  In addition we have shown that antibiotic sensitive Bt 6 
strains are much less pathogenic to hosts that have ingested a single antibiotic 7 
(rifampicin) but antibiotic resistant strains of Bt are not affected in this way.   8 
Therefore in P. xylostella larvae, pathogenicity of Bt or one of its toxins does not 9 
depend upon the culturable gut microbiota. For one strain of Bt (HD-1), and for pure 10 
toxin preparations, the presence of culturable gut microbiota led to a small but 11 
significant reduction in host mortality, implying that the gut microbiota confers some 12 
protection against pathogen attack, as found in other vertebrates and invertebrate hosts 13 
(Jarosz, 1979; Dillon and Charnley, 1995; Filho-Lima et al., 2000; Servin, 2004). A 14 
similar protective role of gut micobiota against the toxicity of pure Cry1Ac was found 15 
in a subsequent paper by Broderick et al (2009) in which antibiotic treatment 16 
increased the susceptibility of Pectinophora gossypiella towards this toxin. These 17 
results also imply that inhibiting the growth of Bt within the host with antibiotics 18 
reduces pathogenicity, indicating that septicaemic proliferation of Bt contributes to 19 
the pathogenicity of this bacterium. Our demonstration of the pathogenicity of 20 
purified Cry toxins in aseptic hosts does not contradict our interpretation of the role of 21 
septicaemia since living bacterial spores have long been known to substantially 22 
increase toxin-induced mortality in P. xylostella and other hosts (Li et al., 1987; 23 
Dubois and Dean, 1995; Liu et al., 1998).  24 
 25 
Page 10 of 30
Society for Applied Microbiology, Editors: K. Timmis, D. Stahl, E. DeLong, M. Wagner, M. Jetten, J.L. Ramos
 10 
Broderick et al. (2006, 2009) reported the importance of culturable gut 1 
microbiota for the pathogenicity of Bt and/or its Cry toxins in a wide range of 2 
Lepidopteran hosts, but our findings do not support this interpretation in diamondback 3 
moth.  Although Broderick et al (2006, 2009) found that treating larvae with 4 
antibiotics inhibited the pathogenicity of Bt in 5 different Lepidpoteran species and 5 
that inoculation with Enterobacter sp. NAB3restored the pathogenicity of Bt in 4 of 6 
these. Their interpretation was that the midgut microbiota commonly contribute to the 7 
pathogenicity of Bt.  Our results suggest that there may be an alternative explanation 8 
for their data.  Just one of the antibiotics they used to produce aseptic larvae 9 
(rifampicin) was sufficient to drastically reduce the pathogenicity of Bt in this study.  10 
Given our results and the fact that orally fed antibiotics can persist in the tissues and 11 
haemolymph of lepidopteran larvae (Sikorowski and Thompson, 1985); it is plausible 12 
that the direct effects of antibiotics, and not the absence of the gut microbiota, account 13 
for the low pathogenicity of Bt in antibiotic-fed Lepidopteran larvae (Broderick et al., 14 
2006; Broderick et al., 2009). Broderick et al (2009) found that administration of 15 
antibiotics to Heliothis virescens larvae greatly reduced subsequent pathogenicity of 16 
Bt. This result is noteworthy as the authors did not detect gut microbiota in H. 17 
virescens larvae prior to antibiotic administration. Thus, in agreement with the results 18 
presented here, the observed attenuation of Bt pathogenicity in antibiotic-treated H. 19 
virescens larvae is likely to result from past antibiotic exposure and not from the 20 
removal of gut microbiota. Broderick et al (2009) inferred that antibiotics were 21 
unlikely to affect Bt because (1) they found similar levels of colony forming units of 22 
Bt in the guts of antibiotic free and antibiotic fed larvae and (2) because E. coli 23 
(engineered to express Bt toxins) and Enterobacter sp. NAB3 could both proliferate in 24 
antibiotic treated larvae.  However, colony counts from gut material may be derived 25 
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from spores and do not imply that the intestine is a suitable site for growth (Raymond 1 
et al., 2008a).  Moreover, gram negative E. coli and Enterobacter spp. are poor 2 
controls for the effects of antibiotics on a gram positive Bacillus; both E. coli and 3 
Enterobacter/Klebsiella are approximately 400 times less susceptible to rifampicin 4 
than gram positive Staphylococci, for example (McCabe and Lorian, 1968).  5 
Broderick et al. (2006) also found that Bt was incapable of growing in filtered 6 
gypsy moth haemolymph.  This, however, is not a typical result. Many studies have 7 
used intra-haemocoelic inoculation to demonstrate that Bt is capable of rapid growth 8 
within the haemocoel of lepidopterans including Callosamia promethean (Edlund et 9 
al., 1976), Cecropia hyalophora (Heierson et al., 1986), Trichoplusia ni (Zhang et al., 10 
1993), Bombyx mori (Fedhila et al., 2004) and Galleria mellonella (Salamitou et al., 11 
2000). Where investigated, it was found that lethal infections were characterised by 12 
rapid growth of Bt within the haemocoel (Heierson et al., 1986). In P. xylostella, 13 
toxin-free spores of B. thuringiensis kurstaki HD1 were found to synergise the 14 
toxicity of purified crystals from the same strain (Miyasono et al., 1994).  Moreover, 15 
synergism was characterised by spore germination and invasion of the larval 16 
haemocoel where B. thuringiensis densities increased to over 106 cells per µl 17 
haemolymph after 72 hours (Miyasono et al., 1994).  18 
We do not contest the possibility that different insect hosts may harbour 19 
facultative pathogens within the mid-gut that could potentially synergize the toxicity 20 
of Cry toxins.  Nevertheless, there are a number of studies suggesting that 21 
antagonistic interactions between the gut microbiota and Bt are probably the norm.  22 
For example, intestinal microbiota invading the cadaver directly compete with Bt for 23 
the limited resources offered by the insect host (Takatsuka and Kunimi, 2000).  It 24 
would therefore make poor adaptive logic for a pathogen to rely upon its competitors 25 
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for full pathogenicity and the action of its highly costly Cry toxins.  Diverse bacterial 1 
antagonists are produced by Bt (Pendleton, 1968; Dong et al., 2002; Nair et al., 2004), 2 
and some of these, for example the quorum quenching N-acyl homoserine lactonases 3 
are clearly targeted at gram negative competitors (Dong et al., 2002).   Finally, mixed 4 
infections with antibiotic producing relatives can increase the pathogenicity of Bt 5 
infections in P. xylostella and the gyspy moth (Broderick et al., 2000; Raymond et al., 6 
2008b).  In one of these studies antibiotic production was associated with the 7 
suppression of natural gut microbiota and domination of the gut community by 8 
Bacillus cereus (Raymond et al., 2008b).  Gut microbiota suppression via in vivo 9 
antibiotic production was therefore implicated in the increased pathogenicity of Bt. 10 
This pattern ties in neatly with the results presented here on the protective role of the 11 
culturable gut microbiota.  In other words suppression of the intestinal microbiota 12 
would seem to be a sound evolutionary strategy for Bt: it may increase the mortality 13 
rates of hosts and also reduce the number of competitors within any resulting cadaver. 14 
 15 
Experimental procedures 16 
Bacterial strains.  17 
Bacillus thuringiensis subsp. kurstaki HD 1 was isolated from a commercial DiPel 18 
stock (DiPel WP, Valent Biosciences Corporation) using Bacillus cereus selective 19 
agar (BcSA) (Oxoid, UK).  Wild-type Bt isolates were collected from a native, 20 
perennial crucifer, Brassica oleracea in semi-natural habitats on the Dorset coast in 21 
the UK and from the Silwood Park campus, Imperial College, UK, using previously 22 
described methods (Collier et al., 2005).  Both habitats adjoin parkland or arable and 23 
pasture crops that are not typically sprayed with Bt biopesticides. Three strains of Bt 24 
(Dt 6.2.y, Dt 7.1.o and C3o20) were shown to be genotypically identical to other Btk 25 
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strains by multilocus-sequence typing of isolates at seven chromosomal genes (ST8, 1 
primers and sequence data available at http://pubmlst.org/bcereus).  All strains were 2 
polymyxin resistant, expressed parasporal inclusions, are pathogenic to P. xylostella, 3 
and carry the genes for Cry1 and Cry2 toxins (B. Raymond unpubl. dat.).  They can 4 
be differentiated from Dipel derived strains by phenotypic antibiotic assays (Nair et 5 
al., 2004) which reveal the improved ability of WT isolates in suppressing the growth 6 
of Pantoea agglomerans (B. Raymond unpubl. dat.)  One of these strains (Dt 6.2.y) 7 
also has improved reproduction in hosts relative to DiPel WP.  A spontaneous 8 
rifampicin resistant mutant derived from DiPel WP, Btk rifR, was described previously 9 
(Raymond et al., 2007). A spontaneous rifampicin resistant strain of Bt HD-73 was 10 
isolated by plating 108-109 cells of overnight culture onto LB agar containing 100 µg 11 
ml-1 rifampicin, and sub-culturing strongly growing colonies.  A description of all 12 
strains used is given in Table 1. For all bioassays fresh spores and crystals of Bt were 13 
prepared by growth on BcSA for 5 days, purification and assessment of spore density 14 
followed established techniques (Raymond et al., 2007). Bacterial stocks were 15 
pasteurized (30 min at 65 oC) and stored at 10°C for no more than 5 days. 16 
Enterobacter sp. Mn2 was isolated from the dissected mid-gut of fourth instar DBM 17 
larvae, reared on Chinese cabbage, Brassica pekinensis, in insect culture rooms at the 18 
Department of Zoology, University of Oxford and identified by sequencing of 16S 19 
rRNA genes using the universal primers 63f (5'- CAG GCC TAA CAC ATG CAA 20 
GTC-3') and 518r (5'- GTA TTA CCG CGG CTG CTG-3') (Genbank accession 21 
number FJ668636). 22 
 23 
Rearing and bioassay of insect larvae  24 
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The Geneva P. xylostella strain was used in all artificial diet experiments (purchased 1 
from CEH Oxford UK). The parents of all aseptically reared larvae were reared on a 2 
wheat-germ based diet (Hunter et al., 1984) containing aureomycin (2.25 g l-1) and 3 
streptomycin (0.25 g l-1).  Thereafter, aseptic larvae were prepared by surface-4 
sterilizing eggs (2% sodium hypochlorite with 100 µl l-1 Triton X100 and three 5 
washes of sterile MilliQ water) and rearing on autoclaved diet in 50mm Petri dishes. 6 
P. xylostella larvae were either reared on rifampicin diet (containing 500 µg ml -1 7 
rifampicin) or antibiotic-free diet.  Experimental inoculation of insects (second or 8 
third instar larvae) with Bt always took place on ≈ 330 mm2 antibiotic-free diet, in 9 
fresh Petri dishes.   Diet was inoculated with 75µl of pasteurized Bt spore/crystal 10 
suspension and three Bt concentrations (200, 400 and 800 spores µl-1) were applied 11 
with 30 larvae tested per dose.  In the Enterobacter sp. Mn2  inoculation treatments Bt 12 
spore/crystal suspensions were prepared in a 1000-fold dilution of an overnight 13 
culture of Enterobacter sp. Mn2 (LB broth 30°C) isolated as described above. Diet 14 
was allowed to dry before larvae were added.  For determination of the toxicity of 15 
purified protoxin, parents of the aseptically-reared larval progeny to be used were 16 
reared on sterile artificial diet containing the antibiotics rifampicin and streptomycin 17 
(100 µg g-1 diet for each).  Eggs derived from these parents were surface sterilized as 18 
described above and larvae were reared on sterile artificial diet containing rifampicin 19 
and streptomycin (100 µg g-1 diet for each)  Parents of non-sterile larvae, and these 20 
larvae prior to exposure to protoxins, were reared on artificial diet without antibiotics 21 
and with no attempt to disrupt vertical transmission of microbes.  22 
 23 
Passage of DiPel derived strains in diamondback moth.  24 
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 We selected for improved reproduction within hosts by passaging Btk rifR in P. 1 
xylostella larvae in four independent evolutionary lineages.  For each lineage we 2 
inoculated ten Brassica pekinensis leaf discs by dipping in suspensions of 2000 spores 3 
µl-1.  Leaf discs were air-dried and placed in 50mm Petri dishes with moistened filter 4 
paper and five third instar larvae that had previously been reared on diet containing 5 
500 µg ml -1 rifampicin.  After seven days cadavers were homogenized in 500 µl 6 
saline and plated onto BcSA containing 100 µg ml-1 rifampicin.  Selection was 7 
imposed by pooling cadavers from each Petri dish at homogenization, so that cadavers 8 
with improved reproduction were better represented in the subsequent strain isolation.  9 
We also selected between Petri dishes within a lineage, by propagating bacteria for 10 
the next passage with approximately equal proportions of bacteria from the five plates 11 
within highest Bt counts. Glycerol stocks were stored at -80°C after each passage. 12 
 13 
Crystal toxin bioassays 14 
Cry1Ac protoxins were expressed as crystals in E. coli, the crystals were purified 15 
away from disrupted cells and stored at -80°C as described previously (Sayyed et al., 16 
2005).  Bioassays were conducted  with five concentrations and third-instar P. 17 
xylostella larvae using discs of sterile artificial diet containing rifampicin and 18 
streptomycin (100 µg g-1 diet for each). Streaking out of purified crystals revealed no 19 
contamination with culturable bacteria.  Each diet disc (  =24 mm, h=10 mm) was 20 
immersed in a Cry1Ac protoxin suspension for 30 s and allowed to dry at room 21 
temperature for 30 min. Suspensions were prepared using sterile distilled water with 22 
Triton X-100 (50 µg ml-1). Control diet discs were immersed in sterile distilled water 23 
with Triton X-100. Each diet disc was added to a sterile 50 ml sample bottle. Five 24 
larvae were sealed in each bottle, and each treatment was repeated six times ( i.e. N = 25 
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30 larvae per dose). Mortality was determined after 120 h at 25°C. Larvae were 1 
considered dead if unable to move when prodded with a blunt, sterile probe. 2 
Bioassays were repeated twice.  3 
 4 
DNA extraction and PCR amplification of DNA from larvae and their gut microbiota   5 
DNA was extracted from whole insects or from over-night cultures of Enterobacter 6 
sp. Mn2 using the CTAB method (Ausubel et al., 1999) and DNA re-suspended in 7 
50µl of 10mM Tris pH 8.0 and stored at -20°C.  PCR amplification with the universal 8 
bacterial 16S rRNA gene primers, 63f and 1492r (Marchesi et al., 1998), was used to 9 
test for the presence of bacteria in larvae.  Amplifications were carried out in 25 µl 10 
reactions containing 0.25 µl Taq polymerase (Qiagen), 1µl dNTPs (10mM stock), 5 11 
pico-moles of each primer, and 2µl of DNA extraction in a Techne Flexigene thermal 12 
cycler.  The reaction conditions were 94°C for 4min followed by 30 cycles of 94°C 13 
for 45s, 57°C for 45s and 72°C for 1m 20s.  In order to establish the sensitivity of the 14 
amplifications to bacterial DNA we ran positive controls with a 10-fold dilution series 15 
of Enterobacter sp. Mn2 DNA.  Control larvae that had been reared on antibiotic-free 16 
diet, and fed on with Enterobacter sp. Mn2 -inoculated diet, were also used as 17 
positive controls to test whether insect DNA or material was an inhibitor of the PCRs. 18 
We did not attempt to amplify 16S rRNA genes from toxin-killed larvae as 19 
chromosomal DNA fragments from Cry toxin-producing bacteria are known to 20 
associate with toxin crystals (Sun et al., 2007) and these fragments could lead to false-21 
positive identification of unculturable mid-gut bacteria. 22 
 23 
Statistical Analysis 24 
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Statistical analysis was carried out in R (http://www.r-project.org) using analysis of 1 
variance, generalized linear modelling, and survival analysis. Cumulative insect 2 
mortality was analysed with survival analysis using Cox proportional hazard models, 3 
where possible.  These models are more powerful than simple analyses of 4 
proportional mortality but rely upon an assumption of a constant probability of death 5 
(Tableman and Sung Kim, 2004).  When this assumption was violated or when 6 
mortality data were available from a single time point proportional mortality was 7 
analysed with generalized linear modelling, a logit-link function and binomial errors 8 
(Crawley, 2005).  The function “quasibinomial” was used to compensate for over-9 
dispersion where appropriate, and estimates of LC50 values with 95% confidence 10 
limits (95% CL) were calculated according to (Collett, 1991). Model assumptions 11 
(normality, homoscedasticity, error distribution) were confirmed with graphical 12 
analyses.  13 
 14 
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 1 
 2 
Table 1.  Bacillus thuringiensis strains used in this study. 3 
 4 
Name Description Source 
DiPel WP, 
DiPel DF 
 
biopesticidal strains of Bt kurstaki HD-1 commercial spore preparations 
HD-1 1971 
 
 
biopesticidal isolate of HD-1 released by 
Institut Pasteur in 1971 
Christina Nielsen-LeRoux 
Btk rifR 
 
 
spontanenous rifampicin resistant mutant of 
DiPel WP 
(Raymond et al. 2007)  
R1-K, R2-K, 
R3-K 
 
strains of Btk rifR independently passaged 
three times in P. xylostella 
this study 
HD-73 
 
Bt kurstaki HD-73  BGSC† 4D4 
HD-73 rifR 
 
 
spontanenous rifampicin resistant mutant of 
HD-73 
this study 
Dt 7.1.o, 
Dt 6.2.y 
 
wild type isolates of B. thuringiensis plant material, Dorset, UK 
C3 o20 wild type isolate of  B. thuringiensis plant material, Ascot, UK, 
(Collier et al. 2005) 
† BGSC- Bacillus Genetic Stock Centre, Ohio State University 5 
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 1 
 2 
Table 2. Effect of intestinal bacteria on the toxicity of Cry1Ac protoxin to third-instar 3 
P. xylostella larvae. 4 
 5 
 6 
Rearing Culturable bacteria  16S rRNA LC50 (ng/ml) 95% CL 
Normal + + 69.3 56.4 - 85.0 
Aseptic§ - - 26.7 21.6 - 32.9 
 7 
§ Larvae were rendered aseptic by treating the parental generation with antibiotics 8 
(100 µg g-1 diet) and by surface sterilization of their eggs. 9 
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 1 
Fig. 1.  Contrasting pathogenicity of different strains of Bt in aseptic hosts treated 2 
with rifampicin. The passaged rifR strains (black lines- filled diamonds) had been 3 
independently cultured three times in P. xylostella larvae; the HD-1 strains were all 4 
derived from biopesticidal sources (dashed lines – open squares); wild-type isolates 5 
(grey lines - asterisks) were collected from plant material in the UK.  Each data point 6 
represents the mean mortality for three strains of each category; bioassays were 7 
replicated three times at different doses for each strain (n = 796 insects overall) 8 
bioassay dose effects have been pooled for graphical simplicity. The data are mean 9 
cumulative proportional mortality + SE. 10 
 11 
Fig. 2.  The effect of the addition of rifampicin and the gut bacterium Enterobacter 12 
sp. Mn2 on the mortality of aseptically reared second instar P. xylostella exposed to 13 
rifampicin susceptible and resistant B. thuringiensis kurstaki HD-1.  Solid symbols 14 
indicate that hosts were reared on rifampicin-amended diet, open symbols indicate 15 
that hosts were reared in the absence of antibiotics.  Circular symbols and grey lines 16 
indicate that Bt was coinfected with Enterobacter sp. Mn2, triangular symbols and 17 
dashed lines indicate that insects were infected with Bt only. In this experiment HD-1 18 
rifR refers to a host- passaged rifampicin resistant derivative of this strain (R1-K). 19 
Bioassays were replicated three times at different doses for each strain (n = 829 20 
insects overall) but dose effects have been pooled for graphical simplicity. The data 21 
are mean cumulative proportional mortality + SE. 22 
 23 
Fig. 3.  The effect of the addition of rifampicin and the gut bacterium Enterobacter 24 
sp. Mn2 on the mortality of aseptically reared third instar P. xylostella exposed to 25 
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rifampicin susceptible and resistant B. thuringiensis kurstaki HD-73.  Solid symbols 1 
indicate that hosts were reared on rifampicin-amended diet, open symbols indicate 2 
that hosts were reared in the absence of antibiotics.  Circular symbols and grey lines 3 
indicate that Bt was coinfected with Enterobacter sp. Mn2, triangular symbols and 4 
dashed lines indicate that insects were infected with Bt only. In this experiment HD-5 
73 rifR refers to a spontaneuous rifampicin resistant derivative of HD-73. Bioassays 6 
were replicated three times at different doses for each strain (n = 767 insects overall) 7 
dose effects did not interact with Enterobacter or diet treatments so dose effects have 8 
been pooled for graphical simplicity. The data are mean cumulative proportional 9 
mortality + SE. 10 
 11 
 12 
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